Exenatide Improved Postprandial Glucose
Reductions at 30 Weeks, Combined Pivotals (Evaluable Meal-tolerance Cohort)
Baseline
100
-30
0
30
60
90
120
150
180
150
200
250
300
Placebo INJ
Meal
Time (minutes)
Glucose mg/dL
Previous slide
Next slide
Back to first slide
View graphic version